Bionique Testing Laboratories LLC was awarded a firm fixed price purchase order valued at $68,826 by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. The contract is for mycoplasma testing laboratory services to support CDC infectious disease prevention and control programs. Bionique Testing Laboratories will utilize its laboratory facilities located in Saranac Lake, New York to provide the specialized diagnostic testing. No set aside designation or...
This federal contract award, valued at $248,779.00, was issued by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, to conduct follow-up testing for tumorigenicity and oncogenicity on the Master Cell Bank (MCB) of Expi293F cells. The contract is a firm-fixed-price purchase order with a completion date of September 24, 2026. The original sources sought notice indicates that the CDC Influenza Division requires cGMP-grade cell...
Genscript USA Inc. has been awarded a $249,900 firm fixed price call against the SARS-COV-2 Surrogate Virus Neutralization Test Kits blanket purchase agreement by the United States Department of Agriculture Animal and Plant Health Inspection Service Marketing and Regulatory Programs Business Services. Under the contract, Genscript will provide SARS-COV-2 surrogate virus neutralization test kits to support the Department of Agriculture's efforts to monitor and research diseases affecting animal...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order valued at $623,036 to American Type Culture Collection, doing business as Atcc, to fulfill a solicitation for the preparation and characterization of purified virus stocks. The solicitation sought proposals for 1,000 vials each of five specified virus types meeting technical requirements for titers, genome copy numbers, sterility, and mycoplasma testing. The contract requires Atcc...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $18,854.28 contract supports the development and validation of new HIV genotyping assays that enable monitoring tools for managing the treatment of HIV-positive patients. This work does not have a set-aside designation. The contract has an ultimate completion date of August 5, 2029....
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company, for plasmid cloning and propagation services. The $11,409.96 contract is for work to be performed in Piscataway, New Jersey. Genscript, which specializes in gene synthesis, gene editing, and other molecular biology services, has received numerous prime and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...
This federal contract award was issued by the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) Veterinary Services to Calbiotech Veterinary Diagnostics, Inc., a foreign-owned, for-profit company. The $173,900.00 firm-fixed-price contract is for the delivery of autorelex virus antibody test kits on an ongoing basis. This delivery order contract has a period of performance through September 30, 2018 and was awarded on December 4, 2015 with no set-aside...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...